Close Monitoring, Full-Time Caregiver Recommended for 30 Days After CAR-T Therapy
Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.
Daily Oncology News
Does Patient Interest Show a Need for Cessation Programs in Lung Cancer Multidisciplinary Clinics?
Researchers surveyed consecutive new patients at a multidisciplinary clinic to determine smokers’ willingness to participate in a cessation program.
Pathologic Stage at RNU Predicts Oncologic Outcomes in High-Grade UTUC
A study found no survival differences between high-grade UTUC patients who at the time of radical nephroureterectomy achieved low-grade disease following neoadjuvant chemotherapy and those who had inherently low-stage disease and did not receive chemotherapy.
Prioritizing Urologic Cancer Cases During the COVID-19 Pandemic
Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.
ETV6 Sequencing Important Among Patients With Inherited Thrombocytopenia, Malignancy
It may be important to sequence ETV6in patients with inherited thrombocytopenia or malignancy and to schedule regular follow-ups to check for secondary cancers.
Remote Care Monitoring Program Allows for Early Pharmacist Intervention to Manage Acute, Delayed CINV
Engaging patients in a CRCMP for CINV allowed for rapid assessment of PROs by a pharmacist, reducing ED visits, hospitalizations, and urgent care use.
Machine Learning Algorithm Predicts Financial Burden Due To Cancer Treatment
Researchers were able to accurately predict financial toxicity among women undergoing mastectomy or lumpectomy for breast cancer.
Study Challenges the Association Between Surgical Margin Size and Breast Cancer Recurrence
Margin size was not associated with locoregional recurrence for patients with breast cancer who underwent breast-conserving surgery and neoadjuvant chemotherapy.
Platinum Therapy May Up Survival in Pancreatic Cancer With DNA Repair Defects
PFS longer in pancreatic ductal adenocarcinoma with versus without homologous recombination deficiency.
Opdivo Plus Yervoy With Limited Chemotherapy Approved for First-Line Metastatic or Recurrent NSCLC
The Food and Drug Administration (FDA) has approved the combination of Opdivo (nivolumab; Bristol Myers Squibb) plus Yervoy (ipilimumab; Bristol Myers Squibb) and 2 cycles of platinum-doublet chemotherapy, for the first-line treatment of adult patients with metastatic or recurrent non-small cell lung cancer (NSCLC), with no EGFR or ALK genomic tumor aberrations.
Real-World Data Suggest Prolonged Lenalidomide Maintenance Therapy Is Beneficial in Patients With MRD-Positive Multiple Myeloma
Findings from this study support use of serial MRD monitoring during lenalidomide maintenance therapy to identify patients likely to benefit from prolonged treatment.
Acute Hospital Care Drives Healthcare Expenditures in Patients With MPN, Study Finds
An additional notable finding from this study was that the absence of specialist care was associated with higher healthcare costs among patients with MPNs.
Study Supports Delaying Cervical Cancer Surgery in COVID-19 Hotspots
Delay in surgery for early-stage cervical cancer was not associated with worse short-term outcomes, supporting the suggestion to delay surgery in COVID-19 hotspots.
Novel Therapies Needed: Poor Prognosis of Patients With TP53-Mutated Myeloid Malignancies
Novel treatment options are needed to improve outcomes for patients with TP53</i-mutated myeloid neoplasms.
Study Links DLBCL and CLL Incidence to Race and Ethnicity, Urban Status
The incidence of DLBCL among Hispanic individuals and CLL among non-Hispanic black individuals was associated with urban status.
Skin Cancer Clinical Trials
Clinical Trial: The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical trial focusing on herditary nonpolyposis colon cancer. The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical Trial: Spectral Diagnosis of Cutaneous Malignancy
Clinical trial focusing on spectral diagnosis. Spectral Diagnosis of Cutaneous Malignancy
Clinical Trial: Electronic Brachytherapy for the Treatment of NMSC
Clinical trial focusing on electronic brachytherapy. Electronic Brachytherapy for the Treatment of NMSC
Clinical Trial: Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical trial focusing on epidermal micrografts. Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical Trial: Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Clinical trial focusing on Mohs surgery project. Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Want to read more?
Please login or register first to view this content.
Next post in Daily Oncology News
